ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Share Price Breaks Above 200-Day Moving Average – Here’s Why

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)’s share price crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $57.12 and traded as high as $57.84. ALPS Medical Breakthroughs ETF shares last traded at $57.60, with a volume of 22,302 shares.

ALPS Medical Breakthroughs ETF Trading Up 1.1%

The firm has a fifty day moving average of $57.79 and a 200 day moving average of $57.16.

Institutional Investors Weigh In On ALPS Medical Breakthroughs ETF

Hedge funds and other institutional investors have recently made changes to their positions in the company. Harbor Investment Advisory LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF during the 2nd quarter valued at approximately $29,000. Fulcrum Equity Management purchased a new stake in ALPS Medical Breakthroughs ETF during the second quarter worth $263,000. Rhodes Investment Advisors Inc. ADV acquired a new stake in ALPS Medical Breakthroughs ETF during the third quarter valued at $266,000. Independent Financial Group LLC acquired a new stake in ALPS Medical Breakthroughs ETF during the first quarter valued at $283,000. Finally, Kestra Advisory Services LLC increased its holdings in ALPS Medical Breakthroughs ETF by 27.6% in the first quarter. Kestra Advisory Services LLC now owns 8,186 shares of the company’s stock valued at $428,000 after buying an additional 1,772 shares in the last quarter.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.